NCT05873283已完成不适用
Is Central Lymph Node Dissection Necessary in Suspected Papillary Thyroid Cancer and Papillary Thyroid Cancer?
Başakşehir Çam & Sakura City Hospital1 个研究点 分布在 1 个国家目标入组 250 人开始时间: 2020年6月12日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 250
- 试验地点
- 1
- 主要终点
- Reaching 100 patients was the first target
研究概览
简要总结
Papillary cancer is a disease that spreads through lymphatic ways and its treatment is surgery. We performed prophylactic central dissection in addition to bilateral total thyroidectomy in patients with bethesda 5 and bethesda 6 biopsy results. We evaluated the pathology results retrospectively.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 85 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •B5 and B6 biopsy results
排除标准
- •lobectomy
结局指标
主要结局
Reaching 100 patients was the first target
时间窗: 18 months
100 patients
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
尚未招募
Unknown
Is routine lymph node dissection recommended for liver resection of intrahepatic cholangiocarcinoma? A systematic review and meta-analysisintrahepatic cholangiocarcinomaJPRN-UMIN000052737Kyoto University
Unknown
不适用
Is Routine Dissection of Central Lymph Node Necessary for Papillary Thyroid Carcinoma, T1-2 N0?Papillary Thyroid CarcinomaNCT04336696Bassem Mohamed Sieda199
招募中
不适用
Prognostic Effect of Whether Doing PLND During RC for High-risk NMIBCBladder CancerNCT05123625The First Affiliated Hospital with Nanjing Medical University200
进行中（未招募）
不适用
Omission of SLNB in Triple-negative and HER2-positive Breast Cancer Patients With rCR and pCR in the Breast After NASTBreast Cancer FemaleBreast CancerNCT04101851Toralf Reimer, MD PhD350
已完成
3 期
Prophylactic Central Lymph Node Dissection in Papillary Thyroid MicrocarcinomaThyroid CancerNCT00795782Samsung Medical Center258